RxDoctor Payments Data

Mary Mattei

Women's Health · Mobile, ALNPI 1619251568

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,142 of the $9,949 with a category attached, or 81.8%. It is spread thinly across 54 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,949in general payments, 2019–2025

Across 452 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics Corporation$2K
  • Eisai Inc.$1K
  • Johnson & Johnson$766
  • Regeneron Healthcare Solutions, Inc.$744
  • Novartis$593
  • Daiichi Sankyo Inc.$547
  • plus $4K from 48 others

What the payments were for

  • Consulting fees$1,80018%
  • Food & beverage$8,14282%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,949 in reported general payments places this provider in the 95th percentile of 107 women's health providers in Alabama.

See all women's health providers in Alabama

Medicare billing

Part B allowed, 2024
$10,563
Medicare patients
79
Services billed
164

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LynparzaOlaparib45$526,044
SancusoGranisetron20$52,397
MyrbetriqMirabegron12$5,525
Letrozole48$1,362
Megestrol Acetate23$1,177
Ondansetron Hcl72$859
Gabapentin34$424
Lidocaine-PrilocaineLidocaine/Prilocaine30$396
Imiquimod13$364
Dexamethasone35$329
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$242
Potassium Chloride14$231
Promethazine Hcl33$154
Prednisone23$132
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$116

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLynparza$529$526,04445 claims
Cumberland Pharmaceuticals, Inc.Sancuso$29$52,39720 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 107 women's health providers in Alabama.

Other women's health in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →